Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Gross Profit (2016 - 2020)

Edesa Biotech's Gross Profit history spans 8 years, with the latest figure at -$1814.0 for Q3 2020.

  • For Q3 2020, Gross Profit changed N/A year-over-year to -$1814.0; the TTM value through Jun 2021 reached -$1814.0, down 100.58%, while the annual FY2020 figure was $311200.0, N/A changed from the prior year.
  • Gross Profit for Q3 2020 was -$1814.0 at Edesa Biotech, down from $108513.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $247086.0 in Q1 2016 and bottomed at -$1.5 million in Q3 2016.
  • The 5-year median for Gross Profit is -$1692.5 (2018), against an average of -$82275.4.
  • The largest annual shift saw Gross Profit plummeted 581.27% in 2016 before it soared 21602.6% in 2020.
  • A 5-year view of Gross Profit shows it stood at $63291.0 in 2016, then crashed by 222.55% to -$77563.0 in 2017, then plummeted by 204.82% to -$236430.0 in 2018, then skyrocketed by 144.0% to $104022.0 in 2019, then crashed by 101.74% to -$1814.0 in 2020.
  • Per Business Quant, the three most recent readings for EDSA's Gross Profit are -$1814.0 (Q3 2020), $108513.0 (Q2 2020), and $100479.0 (Q1 2020).